We are live on ! Find out more
BEAT icon

BioTelemetry
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

195 hedge funds and large institutions have $840M invested in BioTelemetry in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 69 increasing their positions, 68 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 19

80% more capital inflows, than outflows

Capital inflows: $166M | Capital outflows: $92.3M

35% more call options, than puts

Call options by funds: $10.4M | Put options by funds: $7.68M

10% more funds holding

Funds holding: 178 → 195 (+17)

6.4% more ownership

Funds ownership: 81.22% → 87.61% (+6.4%)

1% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 68

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
195
Holders Change
+17
Holders Change %
+9.55%
% of All Funds
4.84%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
36
Increased
69
Reduced
68
Closed
19
Calls
$10.4​M
Puts
$7.68​M
Net Calls
+$2.7​M
Net Calls Change
+$1.34​M

BEAT Hedge Fund Activity: Q2 2017 in Review

195 of the 4,025 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry (BEAT) for Q2 2017, worth a combined $840M — up 27% from $661M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new BEAT positions and 19 closed out — a net gain of 17 holders — while 69 added to existing stakes and 68 trimmed.

The largest buyer was Hood River Capital Management, opening a new position worth an estimated $23.8M. The largest seller was Acadian Asset Management, cutting an estimated $7.58M.

  • 195 institutional investors held BioTelemetry (BEAT) as of Q2 2017, up from 178 in Q1 2017.
  • Funds reported $840M of BioTelemetry stock for Q2 2017, up 27% quarter-over-quarter.
  • 36 funds opened new BioTelemetry positions in Q2 2017 and 19 closed out, a net change of +17 holders.
  • The largest BioTelemetry buyer in Q2 2017 was Hood River Capital Management, an estimated $23.8M added.
  • The largest BioTelemetry seller in Q2 2017 was Acadian Asset Management, an estimated $7.58M sold.

Based on aggregated 13F filings for Q2 2017.